Institutional Ownership
Alaunos Therapeutics Inc
CUSIP 98973P309COM NEWTCRTQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
9.0%
Max % of class reported
Institutional Holders
25
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest Mar 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 5, 2026 | Price Adrian | 13D/A | 8.6% | — | SEC |
| 2 | Feb 24, 2026 | Price Adrian | 13D/A | 8.6% | — | SEC |
| 3 | Dec 5, 2025 | Price Adrian | 13D/A | 8.6% | — | SEC |
| 4 | Oct 31, 2025 | Chris Butterworth | 13D/A | 8.6% | — | SEC |
| 5 | Oct 30, 2025 | Chris Butterworth | 13D | 8.6% | — | SEC |
| 6 | Oct 16, 2025 | Strategic Ep, LLC | 13G/A | — | — | SEC |
| 7 | Sep 5, 2025 | Pmgc Capital LLC | 13D/A | — | — | SEC |
| 8 | Sep 4, 2025 | Strategic Ep, LLC | 13G | 6.8% | 149.8K | SEC |
| 9 | Jul 1, 2025 | Watermill Asset Management Corp. | 13D | 9.0% | — | SEC |
| 10 | May 14, 2025 | Pmgc Capital LLC | 13D | 5.1% | — | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Alaunos Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 22.6K | $64.5K |
| 2 | Blackrock, Inc. | 21.4K | $61.1K |
| 3 | Two Sigma Investments, LP | 10.8K | $31.0K |
| 4 | Citadel Advisors LLC | 10.5K | $30.1K |
| 5 | Xtx Topco Ltd | 10.2K | $29.1K |
| 6 | Ubs Group AG | 2.3K | $6.5K |
| 7 | Osaic Holdings, Inc. | 1.8K | $5.1K |
| 8 | Tower Research Capital LLC (Trc) | 1.6K | $4.5K |
| 9 | Morgan Stanley | 653 | $1.9K |
| 10 | Royal Bank Of Canada | 185 | $1.0K |